Institutional Investors in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) See US$446m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.

Simply Wall St19minutes ago

BTIG Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating

Futu NewsDec 18 19:35 · Ratings

Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Raises Target Price to $112

Futu NewsDec 3 19:31 · Ratings

Procept Biorobotics Insider Sold Shares Worth $2,584,638, According to a Recent SEC Filing

MT NewswiresDec 3 05:19

Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks

Seeking AlphaDec 3 05:12

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

BenzingaDec 3 03:29